# ClinicalTrials.gov record NCT03287960

> PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03287960-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-05-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03287960-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03287960-setmelanotide-v1.json
- Content SHA-256: `c885e031622977dac24b8702ed39f5224c54f522ad14ef25892de0a7f3f17b12`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03287960 ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

## Sources

<a id="source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d"></a>
- **ClinicalTrials.gov record NCT03287960 · retained source version 2023-05-23:71c87a33ef5d995b7ce04b8fa78c4cecf7abec3b24ba5551d2bee29fd50c9fd4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03287960) (`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03287960." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03287960-setmelanotide-v1.json SHA-256: c885e031622977dac24b8702ed39f5224c54f522ad14ef25892de0a7f3f17b12.